title: Experimental arthritis in the rat does not alter the analgesic potency of intrathecal or intraarticular morphine.
abstract: To explore further the role of inflammatory processing on peripheral opioid pharmacology, we examined whether the potency of intraarticular (i.a.) or intrathecal (i.t) morphine in tests of thermal and mechanical nociception changed during the induction of experimental arthritis in the rat. Thermal nociception by i.t. morphine (3, 10, and 50 micrograms) or i.a. morphine (100, 1000, and 3000 micrograms) was assessed by means of a modified Hargreaves box ever) 28 h. Mechanical antinociception was determined for the largest applied doses of morphine using von Frey hairs. Morphine produced dose-dependent thermal antinociception after i.t. or i.a. administration: a 50% increase in maximum antinociceptive thermal response (50% effective dose) was produced by i.t. doses of 9.7 micrograms at the start and 9.1 micrograms at the end of this 28-h observational interval, whereas after i.a. administration, 50% effective dose values were 553 micrograms at the start and 660 micrograms at the end. The largest applied dose of either i.t. or i.a. morphine produced mechanical antinociception. On Day 1, the antinociceptive effect for mechanical nociception (expressed as the area under the curve of the percentage of maximal possible effect values at 0.5, 1, 2, and 4 h) was 68% for i.t. morphine 50 micrograms and 53% for i.a. morphine 3000 micrograms. Neither result differed from the corresponding area under the curve values on Day 2. Naloxone administered either i.t. or i.a. abolished the antinociceptive action of morphine given at the same site. We conclude that, although morphine has a peripheral analgesic site of action in a rat arthritis model, its potency for both i.a. and i.t. routes of administration does not change during the onset of arthritis.
  
  
  CONCLUSIONS
  In this animal study, we showed that the administration of morphine modulates thermal and mechanical antinociception at central and peripheral sites in inflammatory pain.
authors.affiliation: Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Buerkle
authors.forename: E
authors.initials: E
authors.lastname: Pogatzki
authors.forename: M
authors.initials: M
authors.lastname: Pauser
authors.forename: C
authors.initials: C
authors.lastname: Bantel
authors.forename: G
authors.initials: G
authors.lastname: Brodner
authors.forename: T
authors.initials: T
authors.lastname: Möllhoff
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006358:Hot Temperature; D007270:Injections, Intra-Articular; D007278:Injections, Spinal; D007719:Knee Joint; D008297:Male; D009020:Morphine / Q000008:administration & dosage*; D010147:Pain Measurement; D051381:Rats; D017207:Rats, Sprague-Dawley; D012684:Sensory Thresholds
chemical_list: D000701:Analgesics, Opioid; D009020:Morphine